VT-464

· Innocrin Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VT-464, covering 2018-05-07 to 2019-02-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer [Phase 1, Phase 2]

See pricing